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EDITORIAL
Elastography:  French  innovations  in  the
spotlight
In  ﬁfteen  years,  elastography  has  undoubtedly  gained  a  mature  technique  status!  But,  who
would  have  anticipated  in  the  early  2000s  that  elastography  would  have  become  in  a  couple
of  years  this  routine  diagnostic  tool  responsible  for  major  changes  in  the  management  of
so  many  conditions?
The  story  started  in  1999  when  researchers  from  the  ‘‘Laboratoire  Ondes  et  Acoustique’’
(LOA)  of  Paris  VII-Diderot  University  proposed  to  quantify  the  stiffness  of  biological  tissues
using  the  measurement  of  displacements  induced  by  the  propagation  of  pulsed  shear  waves
[1].  Some  of  them  designed  and  marketed  the  FibroScan® (Echosens,  Paris,  France)  that
was  the  ﬁrst  machine  dedicated  to  the  liver  parenchyma  stiffness  measurement,  because
elastography  was  originally  speciﬁcally  designed  for  the  liver.  This  innovation  was  followed
by  an  impressive  success  as  well  as  a  uniform  acknowledgment  of  the  added  medical  value
of  this  new  technology.  Later,  in  2007,  the  French  Haute  Autorité  de  santé  approved  the
use  in  liver  stiffness  measurements  for  the  staging  of  ﬁbrosis  in  hepatitis  C  patients.  This
use  was  further  approved  by  the  European  Association  for  the  Study  of  the  Liver  (EASL)
in  2011  [2].  Another  key  date  was  2011  when  a  group  of  hepatologists  in  Bordeaux  ﬁnally
demonstrated  that  liver  stiffness  measurement  was  an  independent  prognostic  factor  of
5-year  survival  in  patients  with  initial  diagnosis  of  C  viral  hepatitis  [3].  Since  that  time,
the  clinical  impact  of  liver  stiffness  measurement  has  been  validated  worldwide  [4].
Since  then,  elastography  has  become  a  rapidly  developing  ﬁeld  with  frequent  techno-
logical  innovations.  In  this  regard,  each  manufacturer  or  vendor  offers  an  elastography
program.  But  once  again,  the  ‘‘LOA’’  of  Paris  VII-Diderot  University  played  a  pivotal  role
in  this  frantic  technological  race,  with  the  development  of  Supersonic  Shear  Imaging  (SSI),
also  named  2D-shear  wave  elastography  (2D-SWE).  SSI  elastography  available  on  Aixplorer®
US  machines  (Supersonic  Imagine,  Aix-en-Provence,  France)  is  also  based  on  the  measure-
ment  of  the  velocity  of  a  local  shear  wave  through  soft  tissues,  but  herein  the  radiation
force  induced  by  an  ultrasonic  beam  is  combined  with  an  ultrafast  imaging  sequence  capa-
ble  of  catching  in  real  time  the  propagation  of  the  resulting  shear  waves.  By  generating  a
real-time  color  mapping  of  the  elasticity  encoded  pixel  by  pixel  in  an  image  superimposed
on  the  standard  B-mode,  SSI  allows  a  quantitative  imaging  of  the  tissue  elasticity.
Although  the  SSI  technique  is  quite  recent,  ﬁrst  studies  demonstrated  the  potential
clinical  relevance  and  the  accuracy  of  this  new  tool  especially  in  the  ﬁeld  of  liver  ﬁbrosis
or  breast  lesions  [5].  In  this  issue  of  Diagnostic  &  Interventional  Imaging,  two  well-designed
studies  conﬁrmed  the  great  role  that  SSI  can  play  in  the  area  of  diagnostic  ultrasonography.
First,  a  nicely  performed  study  by  Guibal  al.  demonstrated  the  high  degrees  of  diagnostic
accuracy  of  SSI  for  the  staging  of  liver  ﬁbrosis  [6].  Second,  a  well-designed  study  by  Dorado-
Cortez  et  al.  investigated  the  reliability  of  SSI  in  the  ﬁeld  of  muscle  elastography  [7].  Both
studies  nicely  participate  in  the  mounting  evidence  that  SSI  is  an  accurate  and  reliable
elastography  technique.
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However,  there  is  still  a  long  way  to  go  until  elastography
eaches  its  zenith.  First,  performing  reliable  stiffness  mea-
urements  is  not  always  easy  and  requires  some  experience,
herefore  raising  the  issue  of  the  training  of  operators  as
ell  as  the  identiﬁcation  and  validation  of  reliability  crite-
ia  for  each  different  elastography  technique.  Second,  each
lastography  technique  has  its  own  stiffness  values,  ranges
nd  cut-offs.  Regarding  the  liver,  we  noted  in  our  experience
nd  works  that  by  chance,  SSI  values  and  cut-off  values  were
uite  close  to  those  obtained  with  the  FibroScan®,  which
s  convenient  for  its  wide  dissemination  among  hepatolo-
ists  already  familiar  with  the  range  of  FibroScan® values  for
any  years.  However,  the  multiple  available  elastography
echniques  may  conceptually  mirror  the  Tower  of  Babel  [8].
f  note,  should  a  patient  have  follow-up  evaluation  with  dif-
erent  techniques,  it  will  become  difﬁcult  or  even  impossible
o  obtain  a  reliable  assessment  of  possible  changes.  Ide-
lly,  all  manufacturers  and  elastography  researchers  should
ork  together  to  ﬁnd  how  a  harmonization  of  values  should
e  possible  between  the  different  techniques,  and  if  not
ossible,  to  at  least  ﬁnd  the  way  of  converting  or  calibrat-
ng  values  between  these  different  techniques.  This  issue  of
nterplatform  reproducibility  has  been  addressed  using  mag-
etic  resonance  imaging  [9]  but  not  with  ultrasound.  Such  a
omparative  study  would  serve  as  a  template  for  ultrasound
9].
Finally,  the  widespread  implementation  of  elastography
odules  on  most  ultrasound  machines  had  the  advantage
o  expand  the  application  scope  of  elastography  to  other
rgans  than  the  liver,  such  as  the  breast,  thyroid,  kidney,
pleen,  muscles,  or  even  the  vessel  parietal  wall.  As  evi-
ences  are  not  as  mature  in  these  organs  as  they  are  for  the
iver,  many  advances  and  progress  are  expected  for  these
ther  applications  in  the  coming  years.  As  has  been  done  for
he  liver,  we  will  also  need  to  increase  our  understanding
f  technical  and  patient  factors  that  might  affect  elastogra-
hy  performances,  regardless  the  type  of  organ  or  disease
tudied.  Nevertheless,  the  implementation  of  elastography
n  almost  all  ultrasound  machines  allowed  the  radiology
ommunity  to  become  the  cornerstone  regarding  the  devel-
pment  of  elastography,  from  routine  clinical  application
o  future  research  trends.  We  have  to  prove  that  we  are
apable  to  deal  with  and  overcome  all  the  challenges  that
lastography  will  have  to  face  in  a  near  future.Editorial
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